[1]
Y. Matako, K. Suttisingtong, J. Boonsombat, J. Sirirak, and P. Limpachayaporn, “The Synthetic Pathways of a New 1,2,3-Triazole-Containing Sorafenib Analogue and Its Cytotoxicity towards Cancer Cell Lines”, rmutsvrj, vol. 13, no. 1, pp. 244–258, Mar. 2021.